title: Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
abstract: The gene prostate tumor overexpressed 1 (PTOV1) was first found to be upregulated in prostate cancer. This upregulation increased tumor cell proliferation, retinoic acid resistance, and migration. This study investigated the expression and prognostic significance of PTOV1 in hepatocellular carcinoma (HCC). Real-time Polymerase Chain Reaction and western blot analysis were performed to examine PTOV1 expression in 11 HCC cell lines and 2 normal hepatic cell lines. PTOV1 expression levels were also determined in 8 pairs of tissue samples taken from primary HCC tumors and the matched adjacent noncancerous liver tissue from the same patient. Immunohistochemistry assays assessed PTOV1 protein expression in paraffin-embedded clinical samples taken from 215 HCC patients. The correlation of PTOV1 expression with the clinicopathological parameters was evaluated along with the prognostic impact of PTOV1 expression in these HCC patients. PTOV1 mRNA and protein were overexpressed in HCC cell lines compared with normal liver cell lines and were overexpressed in primary HCC samples compared with the matched noncancerous liver tissue samples. In the paraffin-embedded tissue samples from 215 HCC patients, PTOV1 protein expression was significantly correlated with T classification, N classification, clinical stage, and serum α-fetoprotein. HCC patients with higher PTOV1 expression had shorter survival times than patients with lower PTOV1 expression. Our study demonstrated that PTOV1 overexpression is correlated with increased aggressiveness of HCC and could be a prognostic biomarker for patients with HCC.
authors: From the The department of (B-SF, H-MY, N-J) is Department of Hepatic Surgery, The Third Affiliated Hospital of Sun Yat-sen University; Department of Experimental Research, Cancer Center, State Key Laboratory of Oncology in Southern China, Sun Yat-sen University (S-PC); Oncology Department, PLA458 Hospital, Guangzhou (LSZ); and Department of General Surgery, Zengcheng People's Hospital, (BoJi-Affiliated Hospital of Sun Yat-Sen University), Zengcheng, China (X-CZ).
authors: Shu-Peng
authors: SP
authors: Chen
authors: Luo-Sheng
authors: LS
authors: Zhang
authors: Bin-Sheng
authors: BS
authors: Fu
authors: Xian-Cheng
authors: XC
authors: Zeng
authors: Hui-Min
authors: HM
authors: Yi
authors: Nan
authors: N
authors: Jiang
mesh_terms: D000328:Adult; D000368:Aged; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism*; D015153:Blotting, Western; D006528:Carcinoma, Hepatocellular / Q000378:metabolism* / Q000401:mortality* / Q000473:pathology; D045744:Cell Line, Tumor; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007150:Immunohistochemistry; D008113:Liver Neoplasms / Q000378:metabolism* / Q000401:mortality* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009363:Neoplasm Proteins / Q000235:genetics / Q000378:metabolism*; D011379:Prognosis; D012333:RNA, Messenger / Q000378:metabolism; D060888:Real-Time Polymerase Chain Reaction; D015854:Up-Regulation; D000509:alpha-Fetoproteins; D048868:Adaptor Proteins, Signal Transducing
chemical_list: D014408:Biomarkers, Tumor; D009363:Neoplasm Proteins; D012333:RNA, Messenger; D000509:alpha-Fetoproteins; C425183:PTOV1 protein, human; D048868:Adaptor Proteins, Signal Transducing
references: Virchows Arch. 2011 Mar;458(3):323-30
references: 21181414
references: Proc Natl Acad Sci U S A. 2007 Feb 20;104(8):2571-8
references: 17259306
references: Hepatology. 2011 Oct;54(4):1227-36
references: 21688285
references: Nat Rev Cancer. 2003 Apr;3(4):267-75
references: 12671665
references: Gastroenterology. 2012 May;142(6):1264-1273.e1
references: 22537432
references: Cancer Treat Rev. 2011 May;37(3):169-77
references: 20800360
references: J Clin Oncol. 2011 Oct 10;29(29):3892-9
references: 21911725
references: Clin Cancer Res. 2008 May 1;14(9):2617-22
references: 18451224
references: Mol Aspects Med. 2008 Feb-Apr;29(1-2):130-43
references: 18061252
references: Gastroenterology. 2008 Sep;135(3):947-55, 955.e1-5
references: 18639551
references: Hepatology. 1995 Oct;22(4 Pt 1):1027-33
references: 7557847
references: Oncogene. 2001 Mar 22;20(12):1455-64
references: 11313889
references: Mol Cell Biol. 2005 Mar;25(5):1900-11
references: 15713644
references: Oncogene. 2014 Feb 27;33(9):1124-34
references: 23455324
references: Clin Cancer Res. 2008 Jun 1;14(11):3319-26
references: 18519759
references: Am J Pathol. 2003 Mar;162(3):897-905
references: 12598323
references: Clin Chim Acta. 2008 Sep;395(1-2):19-26
references: 18538135
references: Sci Transl Med. 2010 May 19;2(32):32ra35
references: 20484730
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Am J Gastroenterol. 1999 Oct;94(10):2988-93
references: 10520857
references: Gastroenterology. 2007 Jun;132(7):2557-76
references: 17570226